Aprea Therapeutics, Inc. Information Request Form
Levi & Korsinsky announces it has commenced an investigation of Aprea Therapeutics, Inc. (NASDAQ: APRE) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.